Table_5_Elevated gonadotropin levels are associated with increased biomarker risk of Alzheimer's disease in midlife women.DOCX by Matilde Nerattini (17437377)

“…</p>Methods<p>We examined 191 women ages 40–65 years, carrying risk factors for late-onset AD, including 45 premenopausal, 67 perimenopausal, and 79 postmenopausal participants with clinical, laboratory, cognitive exams, and volumetric MRI scans. Half of the cohort completed ¹¹C-Pittsburgh Compound B (PiB) amyloid-β (Aβ) PET scans. …”

Table_7_Elevated gonadotropin levels are associated with increased biomarker risk of Alzheimer's disease in midlife women.DOCX by Matilde Nerattini (17437377)

“…</p>Methods<p>We examined 191 women ages 40–65 years, carrying risk factors for late-onset AD, including 45 premenopausal, 67 perimenopausal, and 79 postmenopausal participants with clinical, laboratory, cognitive exams, and volumetric MRI scans. Half of the cohort completed ¹¹C-Pittsburgh Compound B (PiB) amyloid-β (Aβ) PET scans. …”

Table_2_Elevated gonadotropin levels are associated with increased biomarker risk of Alzheimer's disease in midlife women.DOCX by Matilde Nerattini (17437377)

“…</p>Methods<p>We examined 191 women ages 40–65 years, carrying risk factors for late-onset AD, including 45 premenopausal, 67 perimenopausal, and 79 postmenopausal participants with clinical, laboratory, cognitive exams, and volumetric MRI scans. Half of the cohort completed ¹¹C-Pittsburgh Compound B (PiB) amyloid-β (Aβ) PET scans. …”

Table_4_Elevated gonadotropin levels are associated with increased biomarker risk of Alzheimer's disease in midlife women.DOCX by Matilde Nerattini (17437377)

“…</p>Methods<p>We examined 191 women ages 40–65 years, carrying risk factors for late-onset AD, including 45 premenopausal, 67 perimenopausal, and 79 postmenopausal participants with clinical, laboratory, cognitive exams, and volumetric MRI scans. Half of the cohort completed ¹¹C-Pittsburgh Compound B (PiB) amyloid-β (Aβ) PET scans. …”

Table_6_Elevated gonadotropin levels are associated with increased biomarker risk of Alzheimer's disease in midlife women.DOCX by Matilde Nerattini (17437377)

“…</p>Methods<p>We examined 191 women ages 40–65 years, carrying risk factors for late-onset AD, including 45 premenopausal, 67 perimenopausal, and 79 postmenopausal participants with clinical, laboratory, cognitive exams, and volumetric MRI scans. Half of the cohort completed ¹¹C-Pittsburgh Compound B (PiB) amyloid-β (Aβ) PET scans. …”

Table_1_Elevated gonadotropin levels are associated with increased biomarker risk of Alzheimer's disease in midlife women.DOCX by Matilde Nerattini (17437377)

“…</p>Methods<p>We examined 191 women ages 40–65 years, carrying risk factors for late-onset AD, including 45 premenopausal, 67 perimenopausal, and 79 postmenopausal participants with clinical, laboratory, cognitive exams, and volumetric MRI scans. Half of the cohort completed ¹¹C-Pittsburgh Compound B (PiB) amyloid-β (Aβ) PET scans. …”

Impact of large choroidal vessels (LCV) and topographical orientation on percentage of flow deficit (FD%) values. by Valentin Hacker (9956024)

Gene mapping, mass spectrometry, and purification of the wild-type and p.R163C mutant of human αB-crystallin. by Aref Baharvand (21713886)

Subjects:

DataSheet_1_Pancreatic steatosis and iron overload increases cardiovascular risk in non-alcoholic fatty liver disease.docx by David Marti-Aguado (16739571)

“…MRI-biomarkers of fat fraction (PDFF) and iron accumulation (R2*) were obtained from the liver and pancreas. …”

Longer polyQ sequences decrease the transcriptional activity of AR. by Carlos M. Roggero (11909585)

Flow chart for the inclusion of UK Biobank subjects with paired cMRI and ECG with the respective studies for each cohort. by Mohammad Kayyali (21696054)

The percentages of genes with largely changed expression after AdNKX2-1 infection. by Yuko Ito (1976692)

Flow chart of patient selection. by Julius L. Katzmann (10960479)

Subjects:

Baseline characteristics. by Julius L. Katzmann (10960479)

Subjects:

Drug costs, prevented atherosclerotic cardiovascular disease events, and cost per prevented event. by Julius L. Katzmann (10960479)

Subjects:

Treatment algorithm applied in the simulation study. by Julius L. Katzmann (10960479)

Subjects:

VOC Alpha spike protein shows decreased proteolytic processing. by Daniela Niemeyer (199082)

Decreased MBP levels in <i>Large</i>^{<i>myd/myd</i>} and <i>POMGnT1</i>-KO mice at the RC and OSL. by Shigefumi Morioka (8893511)

Realize large improvements in average NUE by removing low iNUE. by Newell R. Kitchen (12530448)

Structural dynamics of wild-type and p.R163C mutant αB-crystallin dimers: insights from molecular simulations. by Aref Baharvand (21713886)

Subjects: